Citation Impact
Citing Papers
Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli
2007
Schizophrenia risk from complex variation of complement component 4
2016 StandoutNature
The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain
2019 Standout
Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males
2008
Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity
2010
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Sensitive questions in surveys.
2007 Standout
Neuroplasticity of Neocortical Circuits in Schizophrenia
2007
The neuropathology of schizophrenia
1999
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications
2004
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
The cerebellum and cognition
2018 Standout
Structural racism and health inequities in the USA: evidence and interventions
2017 Standout
Prefrontal Norepinephrine Determines Attribution of “High” Motivational Salience
2008
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
Consensus Paper: Cerebellum and Emotion
2016
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
2004
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Glutamate, Dopamine, and Schizophrenia
2003
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Structural Brain Abnormalities in Patients With Schizophrenia and Their Healthy Siblings
2000
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
2003
Schizophrenia
2009 Standout
Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
2003
Effects of Varenicline on Smoking Cue–Triggered Neural and Craving Responses
2011
Dopamine D2 Receptors in the Insular Cortex and the Personality Trait of Novelty Seeking
2001
“More than skin deep”: stress neurobiology and mental health consequences of racial discrimination
2014
Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior
2004
A systems model of altered consciousness: integrating natural and drug-induced psychoses
2001
The free-energy principle: a unified brain theory?
2010 Standout
Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals
2010
Glucose transport to the brain: A systems model
2005
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia
2003
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
2008
The adolescent brain and age-related behavioral manifestations
2000 Standout
Models of schizophrenia in humans and animals based on inhibition of NMDA receptors
2008
Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions
2007
The reduced neuropil hypothesis: a circuit based model of schizophrenia
1999
Prefrontal neurons and the genetics of schizophrenia
2001
The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps?
2006
NMDA receptor hypofunction model of schizophrenia
1999
Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials
2002
Functional Neuroimaging of Attention-Deficit/Hyperactivity Disorder: A Review and Suggested Future Directions
2005
Human Dysbindin (DTNBP1) Gene Expression inNormal Brain and in Schizophrenic Prefrontal Cortex and Midbrain
2004
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Cerebellar Contribution to Social Cognition
2015
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Human endogenous retroviruses with transcriptional potential in the brain
2003
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Functional Connectivity Is Associated With Altered Brain Chemistry in Women With Endometriosis-Associated Chronic Pelvic Pain
2015
Selective impairments in the stress response in schizophrenic patients
2000
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials
2001
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Decreased Somal Size of Deep Layer 3 Pyramidal Neurons in the Prefrontal Cortex of Subjects With Schizophrenia
2001
Effect of cocaine on structural changes in brain: MRI volumetry using tensor-based morphometry
2010
Rethinking schizophrenia
2010 StandoutNature
Beyond diathesis stress: Differential susceptibility to environmental influences.
2009 Standout
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Alterations in the processing of non-drug-related affective stimuli in abstinent heroin addicts
2009
Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine
2010 StandoutNobel
Supra-regional Brain Systems and the Neuropathology of Schizophrenia
1999
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
The social anxiety spectrum
2002
The acute effects of NMDA antagonism: From the rodent to the human brain
2008
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia
2001
Decreased Volume of the Brain Reward System in Alcoholism
2008
Stress-induced increase of testosterone: Contributions of social status and sympathetic reactivity
2008
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
1999
Neuroimaging studies of the hippocampus in schizophrenia
2001
N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study
2003
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder
2003
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
The missing ‘P’ in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care
2013
Proton magnetic resonance spectroscopy in schizophrenia
1999
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
2006
Gene × Disease Interaction on Orbitofrontal Gray Matter in Cocaine Addiction
2011
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
To Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test
2000
Neurocircuitry of Addiction
2009 Standout
Meditation states and traits: EEG, ERP, and neuroimaging studies.
2006 Standout
Antipsychotic-Induced Hyperprolactinaemia
2004
Glutamatergic Animal Models of Schizophrenia
2003
Prescription opioid analgesics rapidly change the human brain
2011
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
The Presynaptic Active Zone Protein RIM1α Is Critical for Normal Learning and Memory
2004 StandoutNobel
Dopamine, learning and motivation
2004 Standout
Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats
2007
Gene Transfer of Mutant Mouse Cholinesterase Provides High Lifetime Expression and Reduced Cocaine Responses with No Evident Toxicity
2013
The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing?
1998
Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres
2009 StandoutNobel
The Role of TDP-43 in Alzheimer’s Disease
2015
Physiological Dysfunction of the Dorsolateral Prefrontal Cortex in Schizophrenia Revisited
2000
Complex brain networks: graph theoretical analysis of structural and functional systems
2009 Standout
Fingerprinting food: current technologies for the detection of food adulteration and contamination
2012 Standout
Current Methods of Assessing Substance Use: A Review of Strengths, Problems, and Developments
2001
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
2000
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
2006 StandoutScience
Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART)
2009
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
A default mode of brain function
2001 Standout
The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia
1999
Imidazole Aldoximes Effective in Assisting Butyrylcholinesterase Catalysis of Organophosphate Detoxification
2014 StandoutNobel
Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype
1998
Endometriosis
2020 Standout
Glutamatergic Mechanisms in Schizophrenia
2002
Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI
2006 Standout
Impairment of Emotional Facial Expression and Prosody Discrimination Due to Ischemic Cerebellar Lesions
2013
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Applications of Clinical Dopamine Imaging
2006
Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC)
2003 Standout
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?
2006
Neurodevelopmental and neurodegenerative hypotheses of schizophrenia: a review and critique
2003
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
1999
Schizophrenia as a Disorder of Neurodevelopment
2002
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
2007
Works of Igor Elman being referenced
Novel CSF biomarkers for frontotemporal lobar degenerations
2010
The Missing P in Psychiatric Training
2011
Reward‐aversion circuitry in analgesia and pain: Implications for psychiatric disorders
2006
Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine
1997
The effects of pharmacological doses of 2-deoxyglucose on cerebral blood flow in healthy volunteers
1999
Decreased Absolute Amygdala Volume in Cocaine Addicts
2004
Acute Effect of Methadone Maintenance Dose on Brain fMRI Response to Heroin-Related Cues
2007
Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia
1999
Pain and analgesia: The value of salience circuits
2013
Alterations in brain structure and functional connectivity in prescription opioid-dependent patients
2010
Dopamine D2 Receptor Density and Personal Detachment in Healthy Subjects
1998
Aversion-Related Circuitry in the Cerebellum: Responses to Noxious Heat and Unpleasant Images
2011
Effect of Acute Metabolic Stress on Pituitary-Adrenal Axis Activation in Patients With Schizophrenia
1998
Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
1998
Inverse relationship between plasma epinephrine and testosterone levels during acute glucoprivation in healthy men
2001
Regionally Specific Neuronal Pathology in Untreated Patients with Schizophrenia: A Proton Magnetic Resonance Spectroscopic Imaging Study
1998
Mechanism of Peripheral Noradrenergic Stimulation by Clozapine
1999
Psychosocial Stress and the Duration of Cocaine Use in Non‐treatment Seeking Individuals with Cocaine Dependence
2003
The Validity of Self‐Reported Drug Use in Non‐Treatment Seeking Individuals with Cocaine Dependence: Correlation with Biochemical Assays
2000
Clozapine and Risperidone in Chronic Schizophrenia: Effects on Symptoms, Parkinsonian Side Effects, and Neuroendocrine Response
1999
Norepinephrine and Schizophrenia: A New Hypothesis for Antipsychotic Drug Action
1997
The cerebellum and addiction: insights gained from neuroimaging research
2013
Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder.
2002
GENDER DIFFERENCES IN COCAINE CRAVING AMONG NON-TREATMENT-SEEKING INDIVIDUALS WITH COCAINE DEPENDENCE
2001
Acute Cortisol Administration Triggers Craving in Individuals with Cocaine Dependence
2025